Skip to main content
OpenTrials
Completed

NCT Number: NCT02662868

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metastatic Breast Cancer Breast Diseases Breast Neoplasms Neoplasm Metastasis Neoplasms Neoplasms by Site Neoplastic Processes Pathologic Processes Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Centro Regional Integrado de Oncologia (CRIO), Fortaleza, Ceará, Brazil

Loading trial locations.

About this study

The primary aim of this study is to characterize patients and treatments of metastatic breast cancer in Brazil. Other specific aims are:

  • to describe patients demographics and socioeconomic characteristics
  • to describe the BC pathological characterization
  • to describe treatment (describe each treatment with dates start-end, cycles, dosing, sequence and line of treatment, reason for discontinuation)
  • to analyze patients outcome (time to progression, site of metastasis, progression free survival (PFS), overall survival (OS), skeletal related events (SRE))

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women > 18 years old
  • Patients diagnosed with de novo or recurrent metastatic breast cancer during the period of January to December 2012
  • Any invasive breast cancer histology and subtype

Exclusion criteria

  • Male breast cancer

Treatment and study plan

Primary outcomes

  1. Description of sociodemographic and socioeconomics characteristics associated to diagnostic and treatment of metastatic breast cancer in Brazil

    Time frame: 8 months

Secondary outcomes

  1. Description of demographic characteristics of metastatic breast cancer patients

    Time frame: 8 months

  2. The clinical and pathological characteristics of patients with metastatic breast cancer

    Time frame: 8 months

  3. Prior treatment for breast cancer before metastatic disease

    Time frame: 8 months

  4. The description of the clinical outcome of the patient diagnosed with metastatic breast cancer

    Time frame: 8 months

  5. Type of treatment after the diagnosis of metastatic breast cancer

    Time frame: 8 months

Sponsors and collaborators

Lead sponsor

Latin American Cooperative Oncology Group

Other

Collaborators

  • Novartis

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jan 26, 2016
Registry last updated
Feb 23, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.